Cargando…

Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission

BACKGROUND: Subclinical synovitis by ultrasound is a frequent finding in rheumatoid arthritis (RA) patients in remission and has been shown to be related to erosive progression, risk of flare and unsuccessful drug tapering, but it has not been investigated how a DAS28 T2T-steered strategy in routine...

Descripción completa

Detalles Bibliográficos
Autores principales: Terslev, Lene, Brahe, Cecilie Heegaard, Østergaard, Mikkel, Fana, Viktoria, Ammitzbøll-Danielsen, Mads, Møller, Torsten, Krabbe, Simon, Hetland, Merete Lund, Døhn, Uffe Møller
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849184/
https://www.ncbi.nlm.nih.gov/pubmed/33522948
http://dx.doi.org/10.1186/s13075-021-02426-w
_version_ 1783645263894675456
author Terslev, Lene
Brahe, Cecilie Heegaard
Østergaard, Mikkel
Fana, Viktoria
Ammitzbøll-Danielsen, Mads
Møller, Torsten
Krabbe, Simon
Hetland, Merete Lund
Døhn, Uffe Møller
author_facet Terslev, Lene
Brahe, Cecilie Heegaard
Østergaard, Mikkel
Fana, Viktoria
Ammitzbøll-Danielsen, Mads
Møller, Torsten
Krabbe, Simon
Hetland, Merete Lund
Døhn, Uffe Møller
author_sort Terslev, Lene
collection PubMed
description BACKGROUND: Subclinical synovitis by ultrasound is a frequent finding in rheumatoid arthritis (RA) patients in remission and has been shown to be related to erosive progression, risk of flare and unsuccessful drug tapering, but it has not been investigated how a DAS28 T2T-steered strategy in routine care affects the presence of subclinical synovitis in RA patients in remission. The aim of the current study was to investigate the presence of ultrasound-detected subclinical inflammation in RA patients in long-term remission receiving either biological or conventional disease-modifying anti-rheumatic drugs (bDMARD/csDMARD) and, finally, to investigate the presence of ultrasound remission using different ultrasound remission criteria. METHODS: Eighty-seven RA patients (42 patients receiving bDMARD and 45 csDMARD) received DAS28-CRP-steered treatment in routine care and had achieved DAS28-CRP-remission for > 1 year without radiographic progression. Twenty-four joints were scored 0–3 by ultrasound (elbows, wrists, knees, ankles, metacarpophalangeal and metatarsophalangeal joints 2–5) for grey-scale synovial hypertrophy (GS) and colour Doppler activity (CD) using the OMERACT scoring system. Ultrasound remission was defined as strict (GS score = 0 and CD score = 0), semi-strict (GS score < 1 and Doppler score = 0) and Doppler remission (Doppler score = 0). RESULTS: No differences between treatment groups were found for GS sum score and Doppler sum score (median (range) 6 (0–19) and 0 (0–12), respectively). A Doppler score > 0 in at least 1 joint was seen in 44%, a GS score > 1 in at least 1 joint in 93% and a GS score > 2 in at least 1 joint in 54% of patients. Strict ultrasound remission was only observed in bDMARD patients (7%; p = 0.01). Thirty-seven per cent were in semi-strict ultrasound remission and 56% in Doppler remission (no significant difference between groups) with similar results across the subgroups of patients who also fulfilled the ACR-EULAR Boolean-, CDAI- and SDAI-remission criteria. CONCLUSIONS: Ultrasound frequently detected subclinical synovitis in RA patients in longstanding DAS28-remission obtained through a DAS28-CRP-steered strategy. This was independent of treatment and applied ultrasound remission criteria. Strict ultrasound remission was rare.
format Online
Article
Text
id pubmed-7849184
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78491842021-02-03 Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission Terslev, Lene Brahe, Cecilie Heegaard Østergaard, Mikkel Fana, Viktoria Ammitzbøll-Danielsen, Mads Møller, Torsten Krabbe, Simon Hetland, Merete Lund Døhn, Uffe Møller Arthritis Res Ther Research Article BACKGROUND: Subclinical synovitis by ultrasound is a frequent finding in rheumatoid arthritis (RA) patients in remission and has been shown to be related to erosive progression, risk of flare and unsuccessful drug tapering, but it has not been investigated how a DAS28 T2T-steered strategy in routine care affects the presence of subclinical synovitis in RA patients in remission. The aim of the current study was to investigate the presence of ultrasound-detected subclinical inflammation in RA patients in long-term remission receiving either biological or conventional disease-modifying anti-rheumatic drugs (bDMARD/csDMARD) and, finally, to investigate the presence of ultrasound remission using different ultrasound remission criteria. METHODS: Eighty-seven RA patients (42 patients receiving bDMARD and 45 csDMARD) received DAS28-CRP-steered treatment in routine care and had achieved DAS28-CRP-remission for > 1 year without radiographic progression. Twenty-four joints were scored 0–3 by ultrasound (elbows, wrists, knees, ankles, metacarpophalangeal and metatarsophalangeal joints 2–5) for grey-scale synovial hypertrophy (GS) and colour Doppler activity (CD) using the OMERACT scoring system. Ultrasound remission was defined as strict (GS score = 0 and CD score = 0), semi-strict (GS score < 1 and Doppler score = 0) and Doppler remission (Doppler score = 0). RESULTS: No differences between treatment groups were found for GS sum score and Doppler sum score (median (range) 6 (0–19) and 0 (0–12), respectively). A Doppler score > 0 in at least 1 joint was seen in 44%, a GS score > 1 in at least 1 joint in 93% and a GS score > 2 in at least 1 joint in 54% of patients. Strict ultrasound remission was only observed in bDMARD patients (7%; p = 0.01). Thirty-seven per cent were in semi-strict ultrasound remission and 56% in Doppler remission (no significant difference between groups) with similar results across the subgroups of patients who also fulfilled the ACR-EULAR Boolean-, CDAI- and SDAI-remission criteria. CONCLUSIONS: Ultrasound frequently detected subclinical synovitis in RA patients in longstanding DAS28-remission obtained through a DAS28-CRP-steered strategy. This was independent of treatment and applied ultrasound remission criteria. Strict ultrasound remission was rare. BioMed Central 2021-02-01 2021 /pmc/articles/PMC7849184/ /pubmed/33522948 http://dx.doi.org/10.1186/s13075-021-02426-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Terslev, Lene
Brahe, Cecilie Heegaard
Østergaard, Mikkel
Fana, Viktoria
Ammitzbøll-Danielsen, Mads
Møller, Torsten
Krabbe, Simon
Hetland, Merete Lund
Døhn, Uffe Møller
Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
title Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
title_full Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
title_fullStr Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
title_full_unstemmed Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
title_short Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
title_sort using a das28-crp-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849184/
https://www.ncbi.nlm.nih.gov/pubmed/33522948
http://dx.doi.org/10.1186/s13075-021-02426-w
work_keys_str_mv AT terslevlene usingadas28crpsteeredtreattotargetstrategydoesnoteliminatesubclinicalinflammationasassessedbyultrasonographyinrheumatoidarthritispatientsinlongstandingclinicalremission
AT brahececilieheegaard usingadas28crpsteeredtreattotargetstrategydoesnoteliminatesubclinicalinflammationasassessedbyultrasonographyinrheumatoidarthritispatientsinlongstandingclinicalremission
AT østergaardmikkel usingadas28crpsteeredtreattotargetstrategydoesnoteliminatesubclinicalinflammationasassessedbyultrasonographyinrheumatoidarthritispatientsinlongstandingclinicalremission
AT fanaviktoria usingadas28crpsteeredtreattotargetstrategydoesnoteliminatesubclinicalinflammationasassessedbyultrasonographyinrheumatoidarthritispatientsinlongstandingclinicalremission
AT ammitzbølldanielsenmads usingadas28crpsteeredtreattotargetstrategydoesnoteliminatesubclinicalinflammationasassessedbyultrasonographyinrheumatoidarthritispatientsinlongstandingclinicalremission
AT møllertorsten usingadas28crpsteeredtreattotargetstrategydoesnoteliminatesubclinicalinflammationasassessedbyultrasonographyinrheumatoidarthritispatientsinlongstandingclinicalremission
AT krabbesimon usingadas28crpsteeredtreattotargetstrategydoesnoteliminatesubclinicalinflammationasassessedbyultrasonographyinrheumatoidarthritispatientsinlongstandingclinicalremission
AT hetlandmeretelund usingadas28crpsteeredtreattotargetstrategydoesnoteliminatesubclinicalinflammationasassessedbyultrasonographyinrheumatoidarthritispatientsinlongstandingclinicalremission
AT døhnuffemøller usingadas28crpsteeredtreattotargetstrategydoesnoteliminatesubclinicalinflammationasassessedbyultrasonographyinrheumatoidarthritispatientsinlongstandingclinicalremission